Page last updated: 2024-09-03

vadimezan and g007-lk

vadimezan has been researched along with g007-lk in 1 studies

Compound Research Comparison

Studies
(vadimezan)
Trials
(vadimezan)
Recent Studies (post-2010)
(vadimezan)
Studies
(g007-lk)
Trials
(g007-lk)
Recent Studies (post-2010) (g007-lk)
2721610126026

Protein Interaction Comparison

ProteinTaxonomyvadimezan (IC50)g007-lk (IC50)
Poly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)0.0343
Cytochrome P450 1A2Homo sapiens (human)0.0045
Cytochrome P450 3A4Homo sapiens (human)0.0581
Cytochrome P450 2C9 Homo sapiens (human)0.0581
Cytochrome P450 2C19Homo sapiens (human)0.0581
Poly [ADP-ribose] polymerase tankyrase-2Homo sapiens (human)0.0386
Protein-serine O-palmitoleoyltransferase porcupineMus musculus (house mouse)0.025

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1

Other Studies

1 other study(ies) available for vadimezan and g007-lk

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023